ROLE OF RETICULOCYTE HEMOGLOBIN CONTENT IN DIAGNOSIS OF IRON DEFICIENCY ANEMIA
DOI:
https://doi.org/10.22159/ajpcr.2023.v16i4.47032Keywords:
Anaemia, Iron Deficiency Anaemia (IDA), Reticulocyte Haemoglobin Content (CHr)Abstract
Objectives: Anemia is a global problem of immense health significance affecting persons of all ages and economic groups. Iron deficiency anemia (IDA) is the most common type of anemia met with in clinical practice. For IDA diagnosis, estimation and treatment, many indices such as serum iron (SI), total iron binding capacity (TIBC), serum ferritin (SF), and soluble transferrin receptor assay are used. But reticulocyte hemoglobin content (CHr) is called as the gold standard for diagnosing IDA as it is the most valuable screening tool for identifying IDA with a sensitivity of 94% and specificity 80% and differentiates IDA from anemia of systemic disease. The present study was undertaken to evaluate CHr as a most efficient marker in diagnosing IDA.
Methods: This prospective observational study was carried out in the Department of General Medicine of M.K.C.G. Medical College and hospital, Berhampur, Odisha, India, from October 2017 to October 2019. Sixty microcytic hypochromic patients of either sex >18 years of age admitted in the medicine ward fulfilling the inclusion and exclusion criteria were included in this study. After taking detailed history and clinical examination, laboratory investigations including complete blood count, SI, serum, ferritin, serum transferrin saturation, TIBC, CHr, and bone marrow aspiration with iron stain were done in all patients.
Results: In the study group of 60 patients, 10 (16.66%) patients had mild anemia, 17 (28.33%) had moderate anemia, and 33 (55%) had severe anemia. Mean hemoglobin of the patients was 6.86 g/dL and SD was 1.95 g/dL. Nineteen (31.66% patients) had TIBC in the range of 351–400 μg/dl. Mean±SD of serum TIBC was 333.91±67.26 μg/dL. Thirty-nine patients (65%) had transferrin saturation in the range of 0.1–10%. The mean±SD of the study group was 13.68±3.22%. Fifty (83.33%) patients had SF in the range of 0–100 μg/dL. Twenty-three patients (38.33%) had CHr concentration between 15.1 and 20 pg followed by 19 (31.66%) between 20.1 and 25 pg and 18 (30%) between 25.1 and 30 pg. The mean±SD of this study was 22.14 pg±3.92.
Conclusion: CHr is found to be a potential biomarker that can be used to differentiate IDA from other causes of anemia.
Downloads
References
Firkin F, Chesterman C, Penington D, Rush B. Iron deficiency and sideroblastic anaemia. In: De Gruchy’s Clinical Hematology in Medical Practice. 6th ed. India: Wiley India Pvt Ltd.; 2013.
Mehta BC, Jhaveri K, Patel JC. Anemia in pregnancy. Indian J Med Sci 1971;25:301-7.
Idris M, Rehman AU. Iron deficiency anaemia in moderate to severely anaemic patient. J Ayub Med Coll Abbottabad 2005;17:108-10.
Henderson PA, Hillman RS. Characteristics of Iron utilization in man. Blood 1969;34:357-75.
Hibbard BM, Hibbard EE. Folate metabolism and pregnancy. Br Med Bull 1968;24:10.
Dutta DC, editors. Medical and Surgical Illness Complicating Pregnancy. Kolkata: New Central Book Agency; 2006.
Burman D. Iron requirements in infancy. Br J Hematol 1971;20:243.
Gordon GH, Pallerson C, Ali M, Singer J, Levine M, Turpie I, et al. Diagnosis of iron deficiency anemia. Am J Med 1990;88:205-9.
Tatsumi N, Izumi T, Reticulocyte maturation index as a useful diagnostic parameter. Sysmes Int 1991;1:23-8.
Piva E, Brugnara C, Chiandetti L, Plebani M. Automated reticulocyte counting: State of the art and clinical applications in the evaluation of erythropoiesis. Clin Chem Lab Med 2010;48:1369-80.
Davis BH, Bigelow NC. Flow cytometric reticulocyte quantification using thiazole orange provides clinically useful reticulocyte maturity index. Arch Pathol Lab Med 1989;113:684-9.
Chang CC, Kass L. Clinical significance of immature reticulocyte fraction (IRF) determined by automated reticulocyte counting. Am J Clin Pathol 1997;108:69-73.
Markovic M, Singh MN, Subota V, Mijusković Z. Reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Clin Lab 2004;50:431-6.
Mateos ME, De-la-Cruz J, Lopez-Laso E, Valdés MD, Nogales A. Reticulocyte hemoglobin content for the diagnosis of iron deficiency. J Pediatr Hematol Oncol 2008;30:539-42.
Ahmad N, Kalakoti P, Bano R, Aarif SM. The prevalence of anemia and associated factors in pregnant women in a rural Indian community. Aust Med J 2011;3:276-80.
Praveen N M,Vijayasimha M, Jayaswal R P, Jha R K. Prevalence of Microcytic and Hypochromic Anemia in Rural Areas of Mysore District (India). Br J Pharm Med Res 2016;1:80-5.
Abel R, Rajaratnam J, Gnanasekaran VJ, Jayaraman P. Prevalence of anemia and iron in the third trimester in rural Vellor district of South India. Trop Doct 2001;31:86-9.
Tater ML, Singh RN, Gupta BD. Serum iron and total iron binding capacity in anemias in children. Indian Pediatr 1999;29:362-4.
Thoradeniya T, Wickremasinghe R, Ramanayake R, Atukorala S. Low folic acid status and its association with anemia in urban adolescent girls and women of child bearing age in Sri Lanka. Br J Nutr 2006;95:511-6.
Van Zeben D, Biger R, Van Wermeskerken RK, Castel A, Hermans J. Evaluation of microcytosis using serum ferritin and red blood cell distribution width. Eur J Haematol 1999;44:106-9.
Mast AE, Blinder MA, Gronowski AM, Chumley C, Scott MG. Clinical utility of the soluble transferrin receptor and comparison with serum ferritin in several populations. Clin Chem 1998;44:45-51.
Karagülle M, Gündüz E, Mutlu FS, Akay MO. Clinical significance of reticulocyte hemoglobin content in the diagnosis of iron deficiency anemia. Turk J Hematol 2013;30:153-6.
Karlosson T. Comparativive evalution of the reticulocyte hemoglobin content assay when screening for iron deficiency in elderly anemic patients. Anemia 2011;2011:925907.
Asif N, Ijaz A, Rafi T, Haroon Z H, Bashir S, Ayyub M. Diagnostic Accuracy of Serum Iron and Total Iron Binding Capacity (TIBC) in Iron Deficiency State. J Coll Physicians Surg Pak. 2016;26:958-61. PMID: 28043306
Fishbane S, Kowalski EA, Imbriano LJ, Maesaka JK. The evaluation of iron status in hemodialysis patients. J Am Soc Nephrol 1996;7:2654-7.
Tessitore N, Solero GP, Lippi G, Bassi A, Faccini GB, Bedogna V, et al. The role of iron status markers in predicting response to intravenous iron in haemodialysis patients on maintenance erythropoietin. Nephrol Dial Transplant 2001;16:1416-23.
Kalanter-Zadeh K, Hoffken B, Wunsch H, Fink H, Kleiner M, Luft FC. Diagnosis of iron deficiency anemia in renal failure patients during the post-erythropoietin era. Am J Kidney Dis 1995;26:292-9.
Dhanwadkar A, Vimal S, Panicker NK, Chanwale SS, Viswanathan V, Kumar H. Study of sideroblasts and iron stores in bone marrow aspirates using Perl’s stain. Med J DY Patil Univ 2016;9:181-5.
Published
How to Cite
Issue
Section
Copyright (c) 2023 Dr Asisha Kumar Pattanayak, Dr. Siba Narayan Jali, Dr. Diptimayee Tripathy, Dr. Nisarg Behera, Dr. Bijaya Kumar Behera
This work is licensed under a Creative Commons Attribution 4.0 International License.
The publication is licensed under CC By and is open access. Copyright is with author and allowed to retain publishing rights without restrictions.
